Jung, T. W. Et Al. 2021. Capmatinib improves insulin sensitivity and inflammation in palmitate-treated C2C12 myocytes through the PPARδ/p38-dependent pathway. Molecular and Cellular Endocrinology , vol.534 .

Jung, T. W., Lee, H. J., Pyun, D. H., Kim, T. J., Bang, J. S., Song, J., ... Shin, Y. K.(2021). Capmatinib improves insulin sensitivity and inflammation in palmitate-treated C2C12 myocytes through the PPARδ/p38-dependent pathway. Molecular and Cellular Endocrinology , vol.534.

Jung, Tae Et Al. "Capmatinib improves insulin sensitivity and inflammation in palmitate-treated C2C12 myocytes through the PPARδ/p38-dependent pathway," Molecular and Cellular Endocrinology , vol.534, 2021

Jung, Tae W. Et Al. "Capmatinib improves insulin sensitivity and inflammation in palmitate-treated C2C12 myocytes through the PPARδ/p38-dependent pathway." Molecular and Cellular Endocrinology , vol.534, 2021

Jung, T. W. Et Al. (2021) . "Capmatinib improves insulin sensitivity and inflammation in palmitate-treated C2C12 myocytes through the PPARδ/p38-dependent pathway." Molecular and Cellular Endocrinology , vol.534.

@article{article, author={Tae Woo Jung Et Al. }, title={Capmatinib improves insulin sensitivity and inflammation in palmitate-treated C2C12 myocytes through the PPARδ/p38-dependent pathway}, journal={Molecular and Cellular Endocrinology}, year=2021}